Last Updated: July 06, 2024
ntrk-fusion-treatment-hcp.com has 6 NS records, 2 A records, 0 AAAA records, 0 MX records, and 0 TXT records. Name servers for ntrk-fusion-treatment-hcp.com are a4-67.akam.net, a1-178.akam.net, a6-65.akam.net, a9-66.akam.net, a7-66.akam.net, a18-66.akam.net. A records for ntrk-fusion-treatment-hcp.com are , 198.21.19.135. The domain's primary website is hosted on a BigIP web server at 198.21.19.135 in United States. The website's description is: "learn about rozlytrek (entrectinib), an fda-approved treatment option for patients with ros1+ mnsclc and certain ntrk fusion+ solid tumors. see full prescribing information for important safety information."
Search DigitalStakeout ASI to find another asset.
No DNS A records
No DNS AAAA records
No DNS MX records
a4-67.akam.net
a1-178.akam.net
a6-65.akam.net
a9-66.akam.net
a7-66.akam.net
a18-66.akam.net
No DNS TXT records
No subdomains found. Please check back at a later time.
BigIP
198.21.19.135
United States
og:site_name: rozlytrek
og:type: website
og:locale: en_us
og:title: rozlytrek (entrectinib) ros1 & trk inhibitor | hcp
og:description: learn about rozlytrek (entrectinib), an fda-approved treatment option for patients with ros1+ mnsclc and certain ntrk fusion+ solid tumors. see full prescribing information for important safety information.
og:url: https://www.rozlytrek-hcp.com/
og:image: https://www.rozlytrek-hcp.com/content/dam/gene/rozlytrek-hcp/global/global_product_logo.genecoreimg.1200.png
og:image:type: image/png
og:image:width: 220
og:image:height: 87
og:image:alt: rozlytrek (entrectinib) ros1 & trk inhibitor
No certificate log entry found for ntrk-fusion-treatment-hcp.com. Please check back at a later time.